search

Active clinical trials for "Foot Ulcer"

Results 571-580 of 661

MIRODERM H2H DFU Study

Diabetic Foot Ulcer

This study will assess the ability of MIRODERM to heal difficult diabetic foot ulcers within 12 weeks of treatment.

Completed32 enrollment criteria

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial

Diabetic Foot Ulcer

This is a follow-up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 3 clinical trial (ALLO-ASC-DFU-301) for 24 months

Completed3 enrollment criteria

Prevention Of Primary Foot Ulcers in High-risk Diabetes Patients

Diabetes MellitusFoot Ulcer2 more

This is a primary prevention study which aims to assess reduction in the rate of diabetic foot ulcers in patients with high-risk diabetic feet using 3D printed insoles compared to standard care

Unknown status13 enrollment criteria

Digital Foot Check by Using the D-Foot, a New Software

Diabetic FootDiabetic Foot Ulcer4 more

Patients with diabetes should be thoroughly examined before they are provided with insoles and shoes. In the study the feet are examined with the help of a new software, the D-Foot. D-Foot includes questions and surveys. The aim of the of the study is evaluate how the patients experience the visit at the department of Prosthetics & Orthotics based on the digital foot check.

Completed6 enrollment criteria

An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the...

Diabetic Foot UlcerNon-healing Wound

This study aims to evaluate the effectiveness of NATROX™ Topical Oxygen Wound Therapy for subjects with non-healing foot ulceration. Subjects will be treated with standard care for 4 weeks. If the wound is not reduced by more than 40%, NATROX™ will be applied for the next 12 weeks. Throughout the study period, wound measurements will be taken to measure wound reduction.

Completed27 enrollment criteria

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial

Diabetic Foot Ulcer

This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1 clinical trial (ALLO-ASC-DFU-101) for 23 months.

Completed3 enrollment criteria

Patients With Diabetic Neuropathy Who Receive Physiotherapy Treatment Will Have a Decrease in Diabetic...

Diabetic Foot UlcerDiabetic Neuropathy Peripheral

This study evaluates the effects of a physiotherapy protocol (manual therapy and exercise) in the prevention of diabetic foot ulcers in patients with diabetic neuropathy. A group of participants will receive a physiotherapy protocol added to their usual medical treatment and the other group will not receive physiotherapy treatment.

Unknown status10 enrollment criteria

Cutoff Value of Ankle Brachial Pressure Index for Vacuum Assisted Closure Application in Diabetic...

Diabetic Foot

Abstract Objective To verify cutoff value of ankle brachial pressure index at which diabetic foot ulcers get benefit from vacuum assisted closure application and to assess impact of its application on ankle brachial pressure index value in the presence of peripheral arterial disease. Methods An observational descriptive prospective analytic study had been performed.56 patients were enrolled in the study. All patients had three sessions of vacuum-assisted closure application. Debridement was done when indicated. Ulcer dimensions were measured before and after each session, while ankle brachial pressure index was measured before the first session .

Completed6 enrollment criteria

Determination of the Pathophysicologic Collagen Changes in the Diabetic Achilles Tendon

Diabetic Foot UlcersEquinus Deformity

This is a pilot study examining tendon collagen, collagen cross-linking, and markers of tendon extracellular matrix metabolism in the Achilles tendon of diabetic patients with ulcerations and amputations of the lower extremity.

Completed12 enrollment criteria

Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis

DiabetesFoot Ulcer1 more

The investigator plans a cohort study of 80 subjects admitted to hospital with a diabetic foot infection in order to compare serial bone biopsies (the current "gold standard") and procalcitonin to diagnose and monitor the effectiveness of therapy for osteomyelitis. The investigator will collect specimens as part of an existing trial to evaluate negative pressure wound therapy in diabetic infected wounds. A high proportion of these patients have osteomyelitis and will receive standard therapy including repeat bone biopsy and parenteral antibiotics. The investigator expects repeated measurement of procalcitonin will be highly correlated with repeated bone biopsy after antibiotic treatment has been completed to determine if therapy has been successful or if additional antibiotic therapy is needed.

Completed6 enrollment criteria
1...575859...67

Need Help? Contact our team!


We'll reach out to this number within 24 hrs